Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice

Herena Eixarch, Alba Gómez, Elisabeth Kádár, Mónica George, Nuria Martínez, Carmen Espejo, Jordi Pétriz, Ramon Gimeno, Jordi Barquinero

    Research output: Contribution to journalArticleResearchpeer-review

    10 Citations (Scopus)

    Abstract

    We investigated whether transgene expression levels influence the immunogenicity of transduced hematopoietic grafts upon transplantation into partially myeloablated mice. To this aim, bone marrow cells (BMCs) transduced with retroviral vectors driving green fluorescent protein (GFP) expression either at high (high-EGFP) or low levels (low-EGFP) were transplanted into congenic recipients conditioned with sublethal doses of total body irradiation (TBI) or busulfan. Virtually all recipients showed evidence of donor engraftment 4 weeks after transplantation. However, as opposed to recipients receiving low-EGFP transduced grafts, the risk of rejecting the EGFP+ cells by 30 days after transplantation was significantly higher in mice conditioned with busulfan and receiving high-EGFP transduced grafts. Anti-EGFP cellular immune responses were demonstrated in high-EGFP-treated mice conditioned with busulfan by interferon-γ (IFN-γ), enzyme-linked immunospot assay (ELISPOT), and cytotoxic T lymphocyte (CTL) assays, in contrast to that observed in mice transplanted with low-EGFP BMC. These results show for the first time that transgene expression levels can be critical for the immunogenicity of gene-modified hematopoietic grafts, especially in immunocompetent or in partially immunosuppressed recipients. These results have profound implications in vector choice and in the design of gene therapy (GT) protocols.
    Original languageEnglish
    Pages (from-to)1904-1909
    JournalMolecular Therapy
    Volume17
    Issue number11
    DOIs
    Publication statusPublished - 26 Aug 2009

    Fingerprint Dive into the research topics of 'Transgene expression levels determine the immunogenicity of transduced hematopoietic grafts in partially myeloablated mice'. Together they form a unique fingerprint.

    Cite this